How much funding has Insight Lifetech raised?

Insight Lifetech has raised $28.0M in total funding, most recently a Series D round.

Who are Insight Lifetech's investors?

Insight Lifetech's investors include Qiming VP, SDIC Unity Capital.

When was Insight Lifetech founded?

Insight Lifetech was founded in 2015.

Where is Insight Lifetech headquartered?

Insight Lifetech is headquartered in Shenzhen, China.

What industry is Insight Lifetech in?

Insight Lifetech operates in Healthcare, Medical Devices.

How many employees does Insight Lifetech have?

Insight Lifetech has 201-500 employees.

Insight Lifetech

IPO

Innovate precision cardiovascular intervention

Shenzhen, China · Founded 2015 · $28.0M raised

Healthcare

Medical Devices

Headquarters: Shenzhen
Employees: 201–500
Founded: 2015
Business Model: B2B

Website: insight-med.com
Total Funding: $28.0M
Last Round: $28.0M Series DJan 2022
Rounds: 3

About

Insight Lifetech Co., Ltd. is a Shenzhen-based medical technology company founded in 2015 with a mission to transform healthcare through innovation and quality. With cardiovascular healthcare as its primary focus, Insight Lifetech develops precision intravascular diagnostic imaging systems, advanced medical ablation products, cardiovascular catheters and accessories, and microcatheter-based FFR solutions. The company's flagship products include the VivoHeart IVUS system, TrueVision IVUS catheter, TrueCross microcatheter for complex coronary interventions, the TruePhysio X wireless pressure microcatheter, and LotosPFA—a nanosecond pulsed field ablation system for atrial fibrillation that was recognized in the first international PFA scientific statement co-released by the Heart Rhythm Society and European Heart Rhythm Association. Insight Lifetech's core team includes scholars from Caltech and Washington University and is backed by first-class venture capital firms from both Silicon Valley and China.

Summary

Insight Lifetech is a Healthcare company based in Shenzhen, China, founded in 2015. It has raised $28.0M in total across 3 rounds, most recently a $28.0M Series D round in Jan 2022. Investors include Qiming VP and SDIC Unity Capital.